Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates

Sponsor
Gao WeiWei (Other)
Overall Status
Unknown status
CT.gov ID
NCT02499744
Collaborator
(none)
200
2
14.9

Study Details

Study Description

Brief Summary

The investigators hypothesize that the Humidified High Flow Nasal Cannula(HHFNC) is effective and safe as primary respiratory support in neonate with respiratory distress syndrome(RDS). It is more convenient in HHFNC combined with kangaroo care.

Condition or Disease Intervention/Treatment Phase
  • Device: NIPPV
  • Device: HHFNC
Phase 1

Detailed Description

Today a new nursing principle proposed that is kangaroo care in neonate.Many study showed kangaroo care may reduce pain、decrease the respiratory and heart rate among preterm infant.The recently study show it benefit to Physical Growth and Neurodevelopment.

Respiratory failure remains a common problem in the neonatal intensive unit. As reported that early non-invasive ventilation is accompanied by significant improvement in subsequent lung development and alveolation.Nasal continuous positive airway pressure (NCPAP)、nasal intermittent positive pressure ventilation(NIPPV) and humidified high flow via nasal cannulas(HHFNC) are non-invasive ventilation models.But Unfortunately, NIPPV and NCPAP systems are not always easily applied or tolerated in the preterm infants.So it is not convenient in kangaroo care.Recently A meta analysis concluded that NIPPV is more effective than NCPAP in preterms respiratory diseases.Maybe the investigators can reason that NIPPV is effective than HHFNC,but there is limited data about the comparison of NIPPV and HHFNC as primary respiratory support in neonate.

The NIPPV group fail definition:1、FiO2>40%、MAP>10 centimeter water column (cm H2O),but SaO2<90%.2、significant abdominal distension.3、PaCO2>60 millimeter of mercury (mmHg)or partial pressure of arterial oxygen (PaO2)<45mmHg.4、severe apnea( definition:>6 episodes requiring stimulation in 6 hours or requiring >1 episodes of positive-pressure ventilation) 5.potential of hydrogen (PH)<7.2 The HHFNC group fail definition:1、FiO2>40%、flow>8 (litre,L)/min,but SaO2<90%.2、significant abdominal distension.3、PaCO2>60mmHg or PaO2<45mmHg.4、severe apnea 5.PH<7.2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Humidified High Flow Nasal Cannula Versus Nasal Intermittent Positive Ventilation in Neonates as Primary Respiratory Support:a Randomized Controlled Trial
Study Start Date :
Feb 1, 2016
Anticipated Primary Completion Date :
May 1, 2017
Anticipated Study Completion Date :
May 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: HHFNC

HHFNC is provided nasal cannula. Ventilator settings:fraction of inspired oxygen (FiO2):21-40%,flow:2-8(litre,L)/min,to maintain arterial blood hemoglobin oxygen saturation ( SaO2) at 90-95% The weaning process is left to the discretion of the attending physician.,when FiO2: 25%,flow:2(litre,L)/min.

Device: HHFNC
For infants in the HHFNC-group who "fail"HHFNC (see definition below), need immediate intubation, a invasive "Rescue-Treatment" may be provided. The decision to attempt "Rescue-Treatment", the mode of respiratory support and the ventilator settings used are at the discretion of the attending clinician.
Other Names:
  • Humidified High Flow Nasal Cannula
  • Active Comparator: NIPPV

    NIPPV is provided via binasal prongs. Ventilator settings:FiO2:21-40%,peak inspiratory pressure( PIP):12-22cm H2O,positive and expiratory pressure(PEEP):5-7cm H2O,Rate:30-60 per minute to maintain SaO2 at 90-95%,The weaning process is left to the discretion of the attending physician,when FiO2: 25%,mean airway pressure (MAP):6cm H2O,R:30 per minute .

    Device: NIPPV
    For infants in the NIPPV-group who "fail"NIPPV (see definition below), need immediate intubation, a invasive "Rescue-Treatment" may be provided. The decision to attempt "Rescue-Treatment", the mode of respiratory support and the ventilator settings used are at the discretion of the attending clinician.
    Other Names:
  • nasal intermittent postive pressure ventilaiton
  • Outcome Measures

    Primary Outcome Measures

    1. endotracheal intubation rate [3 days]

      endotracheal intubation rate assessed within 72 hours after extubation

    Secondary Outcome Measures

    1. significant apnea [7 days]

      significant apnea measured by the Colin J definition:6 episodes requiring stimulation in 6 hours or requiring>1 episodes of positive -pressure ventilation

    2. duration of non-invasive ventilation [3 months]

      the duration of ventilation measured by total non-invasive ventilation time in HHFNC and NIPPV groups

    3. air leaks [3 months]

      air leak assessed by chest X-ray

    4. full enteral feeding [3 months]

      full enteral feeding measured by total feeding dose above 120 ml per kilogram one day

    5. Bronchopulmonary dysplasia [3 months]

      Bronchopulmonary dysplasia assessed by national institute of child health and human development(NICHD) definition

    6. necrotizing enterocolitis [3 months]

      necrotizing enterocolitis assessed by abdominal X-ray and Bell classification

    7. nasal trauma [3 months]

      nasal trauma measured by US national pressure Ulcer Advisory Panel(NPUAP)

    Other Outcome Measures

    1. pain score [3 months]

      pain score assessed by neonatal infant pain scale (NIPS)

    2. neurodevelopment [3 months]

      neurodevelopment assessed by Bayley scale

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A to 28 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Birth weight > 1000 grams and > 28 weeks gestation

    2. have respiratory distress syndrome and need assistant ventilation

    Exclusion Criteria:
    1. Birth weight < 1000 grams

    2. Estimated gestation < 28 weeks

    3. infants have contraindications for use of non-invasive ventilation

    4. Active air leak syndrome

    5. Infants with abnormalities of the upper and lower airways; such as Pierre- Robin, Treacher-Collins, Goldenhar, choanal atresia or stenosis, cleft lip and/or palate, or

    6. Infants with significant abdominal or respiratory malformations including trachea-esophageal fistula, intestinal atresia, omphalocele, gastroschisis, and congenital diaphragmatic hernia.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Gao WeiWei

    Investigators

    • Principal Investigator: yang jie, doctor, Guangdong Women and Children Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Gao WeiWei, professor, Guangdong Women and Children Hospital
    ClinicalTrials.gov Identifier:
    NCT02499744
    Other Study ID Numbers:
    • GuangdongWCHHI
    First Posted:
    Jul 16, 2015
    Last Update Posted:
    Feb 24, 2016
    Last Verified:
    Feb 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Keywords provided by Gao WeiWei, professor, Guangdong Women and Children Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 24, 2016